Intracranial Atherosclerotic Disease and Incident Dementia: The ARIC Study (Atherosclerosis Risk in Communities)
- PMID: 39087353
- PMCID: PMC11513165
- DOI: 10.1161/CIRCULATIONAHA.123.067003
Intracranial Atherosclerotic Disease and Incident Dementia: The ARIC Study (Atherosclerosis Risk in Communities)
Abstract
Background: Studies of the neurovascular contribution to dementia have largely focused on cerebral small vessel disease (CSVD), but the role of intracranial atherosclerotic disease (ICAD) remains unknown in the general population. The objective of this study was to determine the risk of incident dementia from ICAD after adjusting for CSVD and cardiovascular risk factors in a US community-based cohort.
Methods: We acquired brain magnetic resonance imaging examinations from 2011 through 2013 in 1980 Black and White participants in the ARIC study (Atherosclerosis Risk in Communities), a prospective cohort conducted in 4 US communities. Magnetic resonance imaging examinations included high-resolution vessel wall magnetic resonance imaging and magnetic resonance angiography to identify ICAD. Of these participants, 1590 without dementia, without missing covariates, and with adequate magnetic resonance image quality were followed through 2019 for incident dementia. Associations between ICAD and incident dementia were assessed using Cox proportional hazard ratios adjusted for CSVD (characterized by white matter hyperintensities, lacunar infarctions, and microhemorrhages), APOE4 genotype (apolipoprotein E gene ε4), and cardiovascular risk factors.
Results: The mean age (SD) of study participants was 77.4 (5.2) years. ICAD was detected in 34.6% of participants. After a median follow-up of 5.6 years, 286 participants developed dementia. Compared with participants without ICAD, the fully adjusted hazard ratios (95% CIs) for incident dementia in participants with any ICAD, with ICAD only causing stenosis ≤50%, and with ICAD causing stenosis >50% in ≥1 vessel were 1.57 (1.17-2.11), 1.41 (1.02-1.95), and 1.94 (1.32-2.84), respectively. ICAD was associated with dementia even among participants with low white matter hyperintensities burden, a marker of CSVD.
Conclusions: ICAD was associated with an increased risk of incident dementia, independent of CSVD, APOE4 genotype, and cardiovascular risk factors. The increased risk of dementia was evident even among participants with low CSVD burden, a group less likely to be affected by vascular dementia, and in participants with ICAD causing only low-grade stenosis. Our results suggest that ICAD may partially mediate the effect that cardiovascular risk factors have on the brain leading to dementia. Both ICAD and CSVD must be considered to understand the vascular contributions to cognitive decline.
Keywords: dementia; intracranial atherosclerotic disease; plaque; stenosis.
Conflict of interest statement
None.
Similar articles
-
Racial Differences in Prevalence and Risk for Intracranial Atherosclerosis in a US Community-Based Population.JAMA Cardiol. 2017 Dec 1;2(12):1341-1348. doi: 10.1001/jamacardio.2017.4041. JAMA Cardiol. 2017. PMID: 29094154 Free PMC article.
-
Association of Intracranial Atherosclerotic Disease With Brain β-Amyloid Deposition: Secondary Analysis of the ARIC Study.JAMA Neurol. 2020 Mar 1;77(3):350-357. doi: 10.1001/jamaneurol.2019.4339. JAMA Neurol. 2020. PMID: 31860001 Free PMC article.
-
Intracranial atherosclerosis and dementia: The Atherosclerosis Risk in Communities (ARIC) Study.Neurology. 2017 Apr 18;88(16):1556-1563. doi: 10.1212/WNL.0000000000003837. Epub 2017 Mar 22. Neurology. 2017. PMID: 28330958 Free PMC article.
-
Epidemiology, Pathophysiology, and Imaging of Atherosclerotic Intracranial Disease.Stroke. 2024 Feb;55(2):311-323. doi: 10.1161/STROKEAHA.123.043630. Epub 2024 Jan 22. Stroke. 2024. PMID: 38252756 Review.
-
The global burden of cerebral small vessel disease in low- and middle-income countries: A systematic review and meta-analysis.Int J Stroke. 2023 Jan;18(1):15-27. doi: 10.1177/17474930221137019. Epub 2022 Nov 25. Int J Stroke. 2023. PMID: 36282189 Review.
References
Publication types
MeSH terms
Grants and funding
- R01 AG054491/AG/NIA NIH HHS/United States
- U01 HL096812/HL/NHLBI NIH HHS/United States
- U01 HL096917/HL/NHLBI NIH HHS/United States
- R01 HL086694/HL/NHLBI NIH HHS/United States
- U01 HL096902/HL/NHLBI NIH HHS/United States
- U01 HG004402/HG/NHGRI NIH HHS/United States
- 75N92022D00004/HL/NHLBI NIH HHS/United States
- U01 HL096814/HL/NHLBI NIH HHS/United States
- 75N92022D00003/HL/NHLBI NIH HHS/United States
- U01 HL096899/HL/NHLBI NIH HHS/United States
- R01 HL087641/HL/NHLBI NIH HHS/United States
- 75N92022D00001/HL/NHLBI NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- 75N92022D00002/HL/NHLBI NIH HHS/United States
- 75N92022D00005/HL/NHLBI NIH HHS/United States
- R01 HL105930/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
